Finance

Lists
Why is 3378 down 3,02%?
Dive Deeper
3378:HKG
Hanx Biopharmaceuticals (Wuhan) Co Ltd
HK$27,02
-3,02%
(-0,84) 1D
16 Okt., 16:08:14 GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 3378...
Open
HK$27,92
High
HK$27,98
Low
HK$27,02
Mkt. cap
3,62 mjd
Avg. vol.
8,22 k
Volume
3,70 k
52-wk high
HK$33,80
52-wk low
HK$13,48
Shares outstanding
136,22 m
No. of employees
60
Open
HK$27,92
High
HK$27,98
Low
HK$27,02
Mkt. cap
3,62 mjd
Avg. vol.
8,22 k
Volume
3,70 k
52-wk high
HK$33,80
52-wk low
HK$13,48
Shares outstanding
136,22 m
No. of employees
60
News stories
From web sources and news partners
About Hanx Biopharmaceuticals (Wuhan) Co Ltd
CEO-
Employees60
Founded2014
Headquarters-
Sector-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Mrt. 2025
Jun. 2025
Mrt. 2026
Jun. 2026
Revenue
12,50 k
12,50 k
3,00 k
3,00 k
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
15,66 m
15,66 m
13,05 m
13,05 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
13,03 m
13,03 m
13,96 m
13,96 m
Operating expense
28,66 m
28,66 m
26,82 m
26,82 m
Total operating expenses
28,66 m
28,66 m
26,82 m
26,82 m
Operating income
-28,65 m
-28,65 m
-26,81 m
-26,81 m
Other non operating income
-190,50 k
-190,50 k
-8,75 m
-8,75 m
EBT including unusual items
-29,00 m
-29,00 m
-22,47 m
-22,47 m
EBT excluding unusual items
-31,44 m
-31,44 m
-33,05 m
-33,05 m
Income tax expense
-12,17 m
-12,17 m
-5,85 m
-5,85 m
Effective tax rate
41,97%
41,97%
26,02%
26,02%
Other operating expenses
-24,50 k
-24,50 k
-191,00 k
-191,00 k
Net income
-18,22 m
-18,22 m
-18,44 m
-18,44 m
Net profit margin
-145 760,00%
-145 760,00%
-614 716,67%
-614 716,67%
Earnings per share
-
-
-
-
Interest and investment income
163,50 k
163,50 k
3,03 m
3,03 m
Interest expense
-2,77 m
-2,77 m
-519,50 k
-519,50 k
Net interest expenses
-2,60 m
-2,60 m
2,51 m
2,51 m
Depreciation and amortization charges
-
-
-
-
EBITDA
-28,15 m
-28,15 m
-26,09 m
-26,09 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme